Login/Sign Up
₹1652
(Inclusive of all Taxes)
₹1219 with coupons & bank offers*
Get Free delivery (₹99) with
Emvoid 125 mg/80 mg Capsule is a prescription medicine used to prevent nausea and vomiting caused by cancer chemotherapy treatments. It is also used to prevent nausea and vomiting that can happen after surgical procedures. This medicine is specifically designed as a preventive measure and is not used to treat active nausea or vomiting that you already have.
You will typically take Emvoid 125 mg/80 mg Capsule as a multi-day regimen, starting on your first day of chemotherapy or just before surgery. It can be taken with or without food, but it is important to take it exactly at the scheduled times. Emvoid 125 mg/80 mg Capsule is commonly prescribed alongside other antiemetic medicines (such as a 5-HT3 antagonist like ondansetron and a corticosteroid like dexamethasone) as part of a multimodal combination regimen.
Some people taking this medicine may experience mild side effects, such as tiredness, hiccups, or a decreased appetite. While these are usually manageable, please contact your doctor right away if you experience serious symptoms like severe dizziness, yellowing of your skin or eyes, or signs of an allergic reaction.
Before starting Emvoid 125 mg/80 mg Capsule, tell your doctor if you have a history of liver damage, as this medicine is processed by the liver. Do not take this if you are allergic to any of its ingredients or if you are currently taking certain medicines that can cause serious drug interactions.
Emvoid 125 mg/80 mg Capsule can interact with several medicines, including hormonal birth control, making them less effective, so you should use an alternative contraceptive method during and for a month after treatment. Avoid drinking alcohol while taking this medicine as it can worsen drowsiness and stomach irritation. If you are pregnant, breastfeeding, or an elderly patient, discuss the potential risks and benefits with your doctor before starting this treatment.
Emvoid 125 mg/80 mg Capsule is used to prevent nausea and vomiting associated with chemotherapy and surgery. The detailed uses of Emvoid 125 mg/80 mg Capsule are as follows:
Emvoid 125 mg/80 mg Capsule provides important benefits by helping prevent nausea and vomiting during cancer treatment and surgical recovery. The key benefits of Emvoid 125 mg/80 mg Capsule are as follows:
Caution
The interaction of alcohol with Emvoid 125 mg/80 mg Capsule is unknown. If you have any concerns regarding this, please discuss them with your doctor.
Consult your doctor
If you are pregnant or planning pregnancy, inform your doctor before taking Emvoid 125 mg/80 mg Capsule. Your doctor may prescribe this medicine only if clearly needed.
Consult your doctor
It is unknown whether Aprepitant is excreted in breast milk. Hence, if you are a nursing mother, inform your doctor before taking Emvoid 125 mg/80 mg Capsule.
Caution
Emvoid 125 mg/80 mg Capsule may cause dizziness or drowsiness in some people. Hence, do not drive or operate machinery if you feel dizzy or drowsy after taking Emvoid 125 mg/80 mg Capsule.
Consult your doctor
If you have liver disease, inform your doctor before taking Emvoid 125 mg/80 mg Capsule. Your doctor may monitor your liver condition.
Consult your doctor
If you have kidney problems, inform your doctor before taking Emvoid 125 mg/80 mg Capsule.
Unsafe
Emvoid 125 mg/80 mg Capsule is not recommended for children below 12 years of age.
Safe if prescribed
Emvoid 125 mg/80 mg Capsule is generally considered safe, but it’s still important to proceed with medical guidance.
Safe if prescribed
Emvoid 125 mg/80 mg Capsule is generally safe for geriatric individuals. Please consult your doctor if you have any concerns.
Have a query?
The time required for Emvoid 125 mg/80 mg Capsule to start to work: Emvoid 125 mg/80 mg Capsule shows its actions within 4 hours of administration. The time for which the effects of Emvoid 125 mg/80 mg Capsule last: The effect of Emvoid 125 mg/80 mg Capsule usually lasts approximately for 24 hours.
Login/Sign Up
Login/Sign Up
Disclaimer
